LIGAND PHARMACEUTICALS INCORPORATED Proceeds from Royalties Received
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Proceeds from Royalties Received of $0 for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRoyaltiesReceived · last filed 2019-11-08
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from royalties received for the quarter ending 2019-09-30 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from royalties received for the quarter ending 2019-06-30 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from royalties received for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from royalties received for the quarter ending 2018-09-30 was $0.00.
| Period end | Proceeds from Royalties Received 3 month | Proceeds from Royalties Received 6 month | Proceeds from Royalties Received 9 month |
|---|---|---|---|
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $0.00 derived: sum of 2 quarters · filed 2019-11-08 | $0.00 10-Q · filed 2019-11-08 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $0.00 derived: sum of 2 quarters · filed 2019-11-08 | $32.71M 10-Q · filed 2019-11-08 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $32.71M 10-Q · filed 2019-08-08 | |
| 2018-03-31 | $32.71M 10-Q · filed 2019-05-09 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $0.00 10-Q · filed 2018-08-08 | |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-09 |